Search results
AstraZeneca drops GOLDILOX and the porcupine in R&D update
FierceBiotech· 42 minutes agoAstraZeneca’s first quarter results (PDF) put a twist on a fairy tale, telling the lesser-known...
AstraZeneca leaps after smashing first quarter forecasts By Reuters
Investing.com· 2 hours agoOncology, the Anglo-Swedish drugmaker's top business, delivered a 26% jump in first-quarter sales to...
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
Bloomberg· 2 hours agoAstraZeneca Plc’s profit rose in the first quarter, buoyed by demand for its cancer blockbusters Imfinzi and Tagrisso as well as newcomer Enhertu.
AstraZeneca beats revenue, profit estimates on resilient demand
Reuters· 2 hours agoAstraZeneca reported quarterly revenue and profit above market estimates on Thursday, buoyed by...
AstraZeneca Expected to Report Higher Sales But Not Raise Guidance -- Earnings Preview
Market Watch· 17 hours agoAstraZeneca is scheduled to report first-quarter earnings on Thursday. CORE EARNINGS PER SHARE: Core earnings per share--one of the Anglo-Swedish pharmaceutical major's preferred ...
Deutsche Bank Aktiengesellschaft Reiterates “Hold” Rating for AstraZeneca (LON:AZN)
ETF DAILY NEWS· 5 hours agoAstraZeneca (LON:AZN – Get Free Report)‘s stock had its “hold” rating reaffirmed by research analysts at Deutsche Bank Aktiengesellschaft in a research report issued on Tuesday ...
AstraZeneca Beats First-Quarter Revenue, Profit Estimates
US News & World Report· 2 hours agoUS News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.
AstraZeneca confirms strong vaccine protection after US rift
AOL· 1 day agoAstraZeneca insists that its COVID-19 vaccine is strongly effective even after counting additional...
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 2 days agoAstraZeneca AZN will report first-quarter 2024 results on Apr 25, before market open. In the last...
Britain’s Magnificent 7: Do Rolls-Royce, AstraZeneca and Unilever make the cut? By Proactive...
Investing.com· 18 hours agoBritain’s Magnificent 7: Do Rolls-Royce, AstraZeneca and Unilever make the cut?